Thermo Fisher ( (TMO) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Thermo Fisher’s shares are climbing as investors reverse an earlier selloff that followed its Q1 2026 report, which many analysts now call exaggerated. Sentiment improved after the company beat earnings expectations and raised its full-year outlook, easing worries over softer organic growth.
The rebound is getting extra fuel from news that Daniel Loeb’s Third Point LLC has taken a new position in the stock, adding a high-profile vote of confidence. Analysts also highlight that Thermo Fisher increased its annual EPS forecast to a range of $24.64 to $25.12, helping the stock benefit from a broader rally in defensive healthcare names.
More about Thermo Fisher
YTD Price Performance: -19.45%
Average Trading Volume: 2,181,339
Technical Sentiment Signal: Sell
Current Market Cap: $173.3B
For further insights into TMO stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.